The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The prevalence of neurologic and psychiatric diseases has been increasing for decades and, given the moderate therapeutic efficacy and safety profile of existing pharmacological treatments, there is an urgent need for new therapeutic approaches. Nutrition has recently been recognized as an important factor for the prevention and treatment of neuropsychiatric disorders. The omega-3 polyunsaturated fatty acids (n-3 PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) play critical roles in neuronal cell function and neurotransmission as well as inflammatory and immune reactions that are involved in neuropsychiatric disease states. A large number of experimental and epidemiological studies provide a strong basis for interventional clinical trials that assessed the clinical efficacy of n-3 PUFAs in various neurological and psychiatric disorders. Most of these trials found beneficial effects of dietary supplementation with EPA and DHA, and no serious safety concerns have emerged. This review gives an introduction to recent findings on the clinical efficacy of n-3 PUFAs in various neuropsychiatric disorders and the underlying biochemical mechanisms. In addition, the reader will be enabled to identify common methodological weaknesses of clinical studies on n-3 PUFAs, and suggestions for the design of future studies are given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Hibbeln, J. R., Davis, J. M., Steer, C., Emmett, P., Rogers, I., Williams, C., & Golding, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60277-3 · Cited by 987
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Albert, C. M., Gordon, D., Copeland, T., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811403 · Cited by 979
Docosahexaenoic acid: Membrane properties of a unique fatty acid
Stillwell, W., & Wassall, S. R. (2003) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(03)00101-4 · Cited by 872
Omega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-blind, Placebo-Controlled Trial
Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., Cress, K. K., & Marangell, L. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.407 · Cited by 814
Lai, J. S., Hiles, S., Bisquera, A., Hure, A. J., McEvoy, M., & Attia, J. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.069880 · Cited by 786
Passos, I. C., Vasconcelos-Moreno, M. P., Costa, L. G., Kunz, M., Brietzke, E., Quevedo, J., Salum, G., Magalhães, P. V., Kapczinski, F., & Kauer-Sant'Anna, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00309-0 · Cited by 743
Impact of Omega-3 Fatty Acids on the Gut Microbiota
Costantini, L., Molinari, R., Farinon, B., & Merendino, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122645 · Cited by 741
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91658-8 · Cited by 690
Nutritional medicine as mainstream in psychiatry
Sarris, J., Logan, A. C., Akbaraly, T. N., Amminger, G. P., Balanzá-Martínez, V., Freeman, M. P., Hibbeln, J., Matsuoka, Y., Mischoulon, D., Mizoue, T., et al. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00051-0 · Cited by 592
A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression
Lin, P.-Y., Huang, S.-Y., & Su, K.-P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.018 · Cited by 530
Grosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., Drago, F., & Caraci, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096905 · Cited by 449
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Sarris, J., Murphy, J., Mischoulon, D., Papakostas, G. I., Fava, M., Berk, M., & Ng, C. H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091228 · Cited by 436
Bloch, M. H., & Qawasmi, A. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.06.008 · Cited by 417
Maes, M., Smith, R., Christophe, A., Cosyns, P., Desnyder, R., & Meltzer, H. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00092-5 · Cited by 417
Amminger, G. P., Berger, G. E., Schäfer, M. R., Klier, C., Friedrich, M. H., & Feucht, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.007 · Cited by 355
Peet, M., Brind, J., Ramchand, C. N., Shah, S., & Vankar, G. K. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00083-9 · Cited by 329
Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies.
Zheng, J., Huang, T., Yu, Y., Hu, X., Yang, B., & Li, D. (2012) · Public Health Nutrition · doi:10.1017/s1368980011002254 · Cited by 311
Omega-3 for Bipolar Disorder: Meta-Analyses of Use in Mania and Bipolar Depression
Sarris, J., Mischoulon, D., & Schweitzer, I. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06710 · Cited by 284
Bioavailability of marine n-3 fatty acid formulations
Dyerberg, J., Madsen, P., Møller, J. M., Aardestrup, I., & Schmidt, E. B. (2010) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.06.007 · Cited by 256
Chang, J. P.-C., Su, K.-P., Mondelli, V., & Pariante, C. M. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.160 · Cited by 248
Grosso, G., Micek, A., Marventano, S., Castellano, S., Mistretta, A., Pajak, A., & Galvano, F. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.011 · Cited by 244
Zhao, Y., Calon, F., Julien, C., Winkler, J. W., Petasis, N. A., Lukiw, W. J., & Bazan, N. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015816 · Cited by 243
The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
Backes, J., Anzalone, D., Hilleman, D., & Catini, J. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0286-4 · Cited by 195
Sakamoto, T., Cansev, M., & Wurtman, R. J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.089 · Cited by 188
Esteban-Figuerola, P., Canals, J., Fernández-Cao, J. C., & Arija Val, V. (2019) · Autism · doi:10.1177/1362361318794179 · Cited by 181
Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI Study
Pottala, J. V., Yaffe, K., Robinson, J. G., Espeland, M. A., Wallace, R., & Harris, W. S. (2014) · Neurology · doi:10.1212/wnl.0000000000000080 · Cited by 169
Taghizadeh, M., Tamtaji, O. R., Dadgostar, E., Daneshvar Kakhaki, R., Bahmani, F., Abolhassani, J., Aarabi, M. H., Kouchaki, E., Memarzadeh, M. R., & Asemi, Z. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.014 · Cited by 162
Hawkey, E., & Nigg, J. T. (2014) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.05.005 · Cited by 160
Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review
Canhada, S., Castro, K., Perry, I. S., & Luft, V. C. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1321813 · Cited by 156
Ashraf, S. A., Adnan, M., Patel, M., Siddiqui, A. J., Sachidanandan, M., Snoussi, M., & Hadi, S. (2020) · Marine Drugs · doi:10.3390/md18050265 · Cited by 136
Chen, C., Yu, X., & Shao, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139565 · Cited by 133
Healy-Stoffel, M., & Levant, B. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666180412153612 · Cited by 133
Mazahery, H., Conlon, C. A., Beck, K. L., Mugridge, O., Kruger, M. C., Stonehouse, W., Camargo, C. A., Meyer, B. J., Jones, B., & von Hurst, P. R. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.10.017 · Cited by 106
Widenhorn-Müller, K., Schwanda, S., Scholz, E., Spitzer, M., & Bode, H. (2014) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.04.004 · Cited by 103
A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia
Bentsen, H., Osnes, K., Refsum, H., Solberg, D. K., & Bøhmer, T. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.110 · Cited by 97
Mori, M. A., Delattre, A. M., Carabelli, B., Pudell, C., Bortolanza, M., Staziaki, P. V., Visentainer, J. V., Montanher, P. F., Del Bel, E. A., & Ferraz, A. C. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1290928 · Cited by 89
Sánchez-Villegas, A., Álvarez-Pérez, J., Toledo, E., Salas-Salvadó, J., Ortega-Azorín, C., Zomeño, M. D., Vioque, J., Martínez, J. A., Romaguera, D., Pérez-López, J., et al. (2018) · Nutrients · doi:10.3390/nu10122000 · Cited by 72
Hooper, C., de Souto Barreto, P., Coley, N., Cantet, C., Cesari, M., Andrieu, S., & Vellas, B. (2017) · The Journal of nutrition, health and aging · doi:10.1007/s12603-017-0957-5 · Cited by 69
Cardoso, H. D., Santos Junior, E. F. D., de Santana, D. F., Gonçalves-Pimentel, C., Angelim, M. K., Isaac, A. R., Lagranha, C. J., Guedes, R. C. A., Beltrão, E. I., Morya, E., et al. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.023 · Cited by 55
Research works printed but not linked: 166
- 10.1016/S0140-6736(18)32335-3 · DOI · Paper page
- Mental Health Foundation, 2006, Feeding Minds: The Impact of Food on Mental Health
- 10.1002/wps.20223 · DOI · Paper page
- 10.3402/ijch.v62i3.17560 · DOI
- 10.1159/000073791 · DOI · Paper page
- 10.1016/j.plefa.2006.05.013 · DOI · Paper page
- 10.1097/MOL.0000000000000019 · DOI · Paper page
- 10.1016/j.brainres.2008.08.078 · DOI · Paper page
- 10.1007/s11745-001-0804-7 · DOI · Paper page
- 10.1159/000073791 · DOI · Paper page
- 10.1161/JAHA.113.000305 · DOI · Paper page
- 10.1016/j.bbamem.2014.10.036 · DOI
- 10.1016/j.plefa.2012.03.008 · DOI · Paper page
- Costantini L, 2017, Int J Mol Sci, 18
- La Rosa F, 2018, Nutrients, 10
- 10.3233/JAD-2011-111217 · DOI · Paper page
- 10.3181/0711-MR-311 · DOI · Paper page
- 10.1080/10408398.2013.876960 · DOI · Paper page
- 10.1017/jns.2015.26 · DOI
- NOFIMA, 2010, Rapport nr. 196: Lite oksiderte omega-3 oljer og potensielle helsefordeler
- 10.1007/s11746-015-2612-9 · DOI
- 10.1177/0141076815599673 · DOI
- 10.1017/S000711451200164X · DOI
- 10.1007/s00394-013-0503-0 · DOI
- 10.1016/j.plefa.2018.03.003 · DOI
- 10.3390/nu6020799 · DOI · Paper page
- 10.1016/j.chemphyslip.2019.02.006 · DOI
- 10.1016/j.plefa.2018.11.012 · DOI
- 10.1038/ejcn.2014.219 · DOI
- 10.1016/j.plefa.2016.06.004 · DOI
- 10.1007/BF00711429 · DOI
- 10.1017/S0007114514002529 · DOI
- 10.1016/S0140-6736(05)79168-6 · DOI · Paper page
- 10.1159/000203118 · DOI
- 10.1097/PSY.0b013e318188a01e · DOI · Paper page
- 10.1017/S0007114517002768 · DOI
- 10.4088/JCP.09m05895blu · DOI · Paper page
- Sanchez-Villegas A, 2018, Nutrients, 10
- 10.1016/j.plefa.2012.03.002 · DOI
- 10.1111/j.1651-2227.2011.02400.x · DOI
- 10.1097/PSY.0b013e31815aaa42 · DOI · Paper page
- 10.1016/S0165-0327(97)00166-3 · DOI · Paper page
- 10.1016/j.chc.2014.02.002 · DOI
- 10.7205/MILMED-D-14-00153 · DOI · Paper page
- 10.1159/000339264 · DOI · Paper page
- Colin A, 2003, Encephale, 29, 49
- 10.1001/archpsyc.59.10.913 · DOI · Paper page
- 10.1001/jama.2009.1487 · DOI · Paper page
- 10.4088/JCP.10m06634 · DOI · Paper page
- 10.1111/appy.12335 · DOI
- 10.1080/07315724.2009.10719785 · DOI · Paper page
- 10.1016/j.pnpbp.2017.06.020 · DOI · Paper page
- 10.1016/j.plefa.2017.03.004 · DOI
- 10.1176/appi.ajp.160.12.2222 · DOI · Paper page
- 10.1093/ajcn/78.1.40 · DOI · Paper page
- 10.1176/ajp.2006.163.6.1098 · DOI · Paper page
- 10.1038/tp.2017.190 · DOI · Paper page
- 10.2174/1871527311312040005 · DOI
- 10.1016/j.biopsych.2009.11.005 · DOI · Paper page
- 10.1016/S0920-9964(97)00151-5 · DOI · Paper page
- 10.1016/0920-9964(94)90043-4 · DOI · Paper page
- 10.1016/S0952-3278(96)90148-9 · DOI · Paper page
- 10.1176/appi.ajp.159.9.1596 · DOI · Paper page
- 10.5539/gjhs.v6n7p103 · DOI · Paper page
- 10.4088/JCP.v68n1206 · DOI · Paper page
- 10.1016/S0022-3956(01)00048-6 · DOI · Paper page
- 10.1176/appi.ajp.158.12.2071 · DOI · Paper page
- 10.1016/j.jpsychires.2015.11.013 · DOI
- 10.1016/j.jpsychires.2013.01.016 · DOI
- 10.1016/j.pnpbp.2018.11.022 · DOI
- 10.1016/j.plefa.2017.05.004 · DOI
- 10.1038/sj.npp.1301628 · DOI
- 10.1007/s00787-016-0932-4 · DOI
- 10.1016/j.biopsych.2013.06.007 · DOI · Paper page
- 10.1007/s00431-009-1035-8 · DOI · Paper page
- 10.1371/journal.pone.0066697 · DOI · Paper page
- 10.1371/journal.pone.0156432 · DOI · Paper page
- 10.1002/hup.2313 · DOI · Paper page
- 10.1111/jcpp.12314 · DOI
- 10.23736/S0026-4946.18.04975-7 · DOI
- 10.1002/14651858.CD007986.pub2 · DOI · Paper page
- 10.1093/nutrit/nux064 · DOI
- 10.1016/j.jpsychires.2018.12.002 · DOI
- 10.1111/jcpp.12932 · DOI
- 10.1016/j.clnesp.2018.03.126 · DOI
- 10.2147/NDT.S68652 · DOI
- 10.1016/0952-3278(92)90155-C · DOI
- Alden PB, 1986, Surgery, 100, 671
- 10.1016/j.jad.2016.08.021 · DOI
- Kalinic D, 2014, Croat Med J, 55, 27
- 10.1159/000351993 · DOI
- 10.1097/JCP.0b013e3181d48830 · DOI
- 10.4088/JCP.14m09260 · DOI
- 10.1016/j.jad.2016.05.054 · DOI
- 10.1159/000336811 · DOI
- 10.1371/journal.pone.0057945 · DOI
- 10.1159/000322980 · DOI · Paper page
- 10.1007/s00394-017-1462-7 · DOI
- 10.1016/j.plefa.2018.03.006 · DOI
- 10.1016/j.jpain.2015.04.007 · DOI
- 10.2174/1574884713666180807145648 · DOI
- Burckhardt M, 2016, Cochrane Database Syst Rev, 4
- 10.1037/neu0000373 · DOI
- 10.1159/000448805 · DOI · Paper page
- 10.3945/ajcn.115.124081 · DOI · Paper page
- 10.20344/amp.7970 · DOI
- 10.1016/j.jnutbio.2016.03.002 · DOI
- 10.1016/j.jalz.2007.10.005 · DOI · Paper page
- 10.1179/1476830512Y.0000000026 · DOI · Paper page
- 10.3233/JAD-2010-090934 · DOI · Paper page
- 10.1254/jphs.10R33FM · DOI
- 10.1523/JNEUROSCI.0055-07.2007 · DOI · Paper page
- 10.1016/j.bbalip.2005.11.011 · DOI
- 10.1523/JNEUROSCI.4225-04.2005 · DOI · Paper page
- 10.1016/j.ebiom.2018.05.028 · DOI
- 10.3233/JAD-150886 · DOI · Paper page
- 10.1136/bmj.39289.437454.AD · DOI · Paper page
- Boyko AA, 2017, Int J Mol Sci, 18
- 10.1016/S1353-8020(99)00029-2 · DOI
- 10.1001/jama.2014.3654 · DOI · Paper page
- Kalinderi K, Int J Neurosci, 2018, 1
- 10.1093/ajcn/86.5.1486 · DOI · Paper page
- 10.1111/j.1468-1331.2011.03600.x · DOI
- 10.1212/01.WNL.0000166038.67153.9F · DOI · Paper page
- 10.1016/j.jns.2009.09.021 · DOI
- 10.1016/j.plefa.2012.05.008 · DOI
- 10.1136/jnnp-2014-307749 · DOI
- 10.1016/j.yebeh.2018.08.016 · DOI
- 10.1186/s40169-019-0220-2 · DOI
- 10.1016/j.yebeh.2011.11.030 · DOI
- 10.1093/jn/nxy116 · DOI
- 10.1371/journal.pone.0197759 · DOI
- 10.1080/01616412.2017.1382800 · DOI
- Pantzaris MC, 2013, BMJ Open, 3
- 10.1177/1535370215618462 · DOI
- 10.1089/cap.2016.0123 · DOI · Paper page
- 10.1089/cap.2015.0132 · DOI · Paper page
- 10.4088/JCP.14m09267 · DOI
- 10.1016/j.plefa.2004.03.007 · DOI
- 10.1002/eat.10235 · DOI · Paper page
- 10.1002/eat.22964 · DOI
- 10.1007/s40261-017-0617-x · DOI
- 10.1177/070674371305800705 · DOI · Paper page
- 10.1176/appi.ajp.160.1.167 · DOI · Paper page
- 10.1007/s10803-018-3860-y · DOI
- 10.1093/jn/nxx047 · DOI
- 10.2147/NDT.S147305 · DOI · Paper page
- 10.1016/j.clnu.2011.11.015 · DOI
- Bahagat KA, 2019, An Pediatr (Barc)
- 10.1016/j.yebeh.2007.10.015 · DOI
- 10.1177/1352458517691150 · DOI
- 10.1111/bdi.12633 · DOI
- 10.1111/bdi.12386 · DOI · Paper page
- 10.1111/bdi.12337 · DOI
- Esteban-Figuerola P, Autism, 2018, 136236131879417
- 10.1093/jnci/djt174 · DOI · Paper page
- 10.1093/jnci/dju015 · doi:10.1093/jnci/dju015
- 10.1093/jnci/dju019 · doi:10.1093/jnci/dju019
- 10.1093/jnci/dju014 · doi:10.1093/jnci/dju014
- 10.1016/j.clnu.2017.03.027 · DOI · Paper page
- FDA, 2004, Federal Register, 69
- EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2012, EFSA Journal, 10
- 10.1051/rnd:19910501 · DOI · Paper page
- 10.1016/S0006-291X(88)80718-6 · DOI · Paper page
- 10.1038/ejcn.2010.239 · DOI · Paper page
- 10.1016/j.bbalip.2003.10.003 · DOI
Cited by
Ashraf, S. A., Adnan, M., Patel, M., Siddiqui, A. J., Sachidanandan, M., Snoussi, M., & Hadi, S. (2020) · Marine Drugs · doi:10.3390/md18050265 · Cited by 136
“The EPA and DHA fatty acids found in fish also exhibit anti-inflammatory properties through their impact on prostaglandin synthesis [94,98].”
BackgroundAwuchi, C. G., Chukwu, C. N., Iyiola, A. O., Noreen, S., Morya, S., Adeleye, A. O., Twinomuhwezi, H., Leicht, K., Mitaki, N. B., & Okpala, C. O. R. (2022) · BioMed Research International · doi:10.1155/2022/3661866 · Cited by 102
“The 6 BioMed Research International anti-in fl ammatory property of EPA and DHA occurs via modulation of prostaglandin synthesis [61, 85].”
Cyanobacteria and microalgae in supporting human habitation on Mars
Mapstone, L. J., Leite, M. N., Purton, S., Crawford, I. A., & Dartnell, L. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.107946 · Cited by 92
“These fats have multiple roles in metabolism, including promoting brain health and reducing neuropsychiatric disorders (Derbyshire, 2018; Reimers and Ljung, 2019), aiding in immune system signalling (Guti ´ errez et al., 2019) and maintaining the cardiovascular system (Pizzini et al., 2018;…”
Lorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69
Metadata
- Authors
- Reimers, A., & Ljung, H.
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2019-01
- Volume
- 9
- Pages
- 2045125319858901-2045125319858901
- ISSN
- 2045-1253 (ISSN-L)
- 2045-1261
- OpenAlex
- W2954933079
- Cited by
- 75
- References
- 40
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.